BCY17901 TFA
Product Specifications
Target
Others
Related Pathways
Others
Bioactivity
BCY17901 TFA is a potent irreversible inhibitor of transferrin receptor 1 (TfR1) with a Ki value of 12 nM. It disrupts TfR1-mediated endocytosis and iron transport, thereby inhibiting the proliferation of tumor cells reliant on iron metabolism. BCY17901 TFA is applicable in research on solid tumors, such as breast cancer and glioblastoma, as well as neurodegenerative diseases.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
U1000-19-ML405 100 µL
UBQLN2, NT (Ubiquilin 2, Protein Linking IAP with Cytoskeleton-2, PLIC-2, hPLIC-2, Ubiquitin-like Product Chap1/Dsk2, DSK2 Homolog, Chap1, N4BP4, PLIC2, HRIHFB2157) (MaxLight 405) discontinued
Ask
View Details 
035723-ML405 100 µL
FOXB2, NT (FOXB2, Forkhead box protein B2) (MaxLight 405) discontinued
Ask
View Details MBS9025509-01 0.02 mg (E-Coli)
Human Apoptosis-resistant E3 ubiquitin protein ligase 1 (AREL1), partial-length
Ask
View Details MBS9025509-02 0.02 mg (Yeast)
Human Apoptosis-resistant E3 ubiquitin protein ligase 1 (AREL1), partial-length
Ask
View Details 
MBS9025509-03 0.1 mg (E-Coli)
Human Apoptosis-resistant E3 ubiquitin protein ligase 1 (AREL1), partial-length
Ask
View Details MBS9025509-04 0.1 mg (Yeast)
Human Apoptosis-resistant E3 ubiquitin protein ligase 1 (AREL1), partial-length
Ask
View Details